Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Vxr, Inc. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

61 daysmedian FDA review time
79 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K853703VENTREZYME T3 IMMUNOASSAY T3Vxr, Inc.1985-10-04300
K853748VENTRESCREEN HCG URINEVxr, Inc.1985-10-01220
K841456VENTREXYME EIA CONTROLS IMMUNOASSAYVxr, Inc.1984-05-21420
K840473VENTREZYME T4 IMMUNOASSAY T4Vxr, Inc.1984-04-04610
K833960VENTREX PREGNANCY TEST KIT ENZYMEVxr, Inc.1984-02-03790
K833989VENTREZYME THEOPHYLLINE IMMUNOASSAYVxr, Inc.1984-01-30730
K833878VENTREZYME DIGOXIN IMMUNOASSAY DIGOXVxr, Inc.1984-01-13660
K833909VENTRESCREEN BETA-HCG ENZYME IMMUNOVxr, Inc.1983-11-2170

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda